Editas Medicine (EDIT) Share-based Compensation (2015 - 2025)
Editas Medicine (EDIT) reported Share-based Compensation of $2.2 million for Q3 2025, down 53.6% year-over-year from $4.8 million in Q3 2024, and down 16.37% on a QoQ basis from $2.7 million in Q2 2025.
Editas Medicine (EDIT) has 11 years of Share-based Compensation data on file, last reported at $2.2 million in Q3 2025.
- Quarterly Share-based Compensation fell 53.6% year-over-year to $2.2 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $11.9 million (down 47.71% YoY) and the FY2024 annual result came in at $21.4 million, up 8.18% from the prior year.
- Share-based Compensation declined to $2.2 million in Q3 2025 per EDIT's latest filing, from $2.7 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $13.5 million in Q2 2021 and bottomed at $2.2 million in Q3 2025.
- The 5-year median for Share-based Compensation is $5.3 million (2023), against an average of $6.4 million.
- The widest annual swing landed in 2021, when Share-based Compensation soared 149.7%; it then tumbled 60.73% in 2025.
- Tracing EDIT's Share-based Compensation over 5 years: stood at $7.7 million in 2021, then dropped by 29.95% to $5.4 million in 2022, then decreased by 0.35% to $5.3 million in 2023, then retreated by 24.79% to $4.0 million in 2024, then slumped by 44.58% to $2.2 million in 2025.
- Per Business Quant, the three latest EDIT Share-based Compensation figures stand at $2.2 million (Q3 2025), $2.7 million (Q2 2025), and $3.0 million (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 892,057.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 305,000.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 166.40 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 257.40 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 70.15 Mn |
| 10 | Editas Medicine | 338.62 Mn | 338.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 2.23 Mn |
| Sep 30, 2025 | 2.23 Mn |
| Jun 30, 2025 | 2.66 Mn |
| Jun 30, 2025 | 2.66 Mn |
| Mar 31, 2025 | 2.98 Mn |
| Mar 31, 2025 | 2.98 Mn |
| Dec 31, 2024 | 4.02 Mn |
| Dec 31, 2024 | 4.02 Mn |
| Sep 30, 2024 | 4.80 Mn |
| Sep 30, 2024 | 4.80 Mn |
| Jun 30, 2024 | 5.01 Mn |
| Jun 30, 2024 | 5.01 Mn |
| Mar 31, 2024 | 7.59 Mn |
| Mar 31, 2024 | 7.59 Mn |
| Dec 31, 2023 | 5.35 Mn |
| Dec 31, 2023 | 5.35 Mn |
| Sep 30, 2023 | 4.73 Mn |
| Sep 30, 2023 | 4.73 Mn |
| Jun 30, 2023 | 5.22 Mn |
| Jun 30, 2023 | 5.22 Mn |
| Mar 31, 2023 | 4.51 Mn |
| Mar 31, 2023 | 4.51 Mn |
| Dec 31, 2022 | 5.36 Mn |
| Dec 31, 2022 | 5.36 Mn |
| Sep 30, 2022 | 5.88 Mn |
| Sep 30, 2022 | 5.88 Mn |
| Jun 30, 2022 | 6.62 Mn |
| Jun 30, 2022 | 6.62 Mn |
| Mar 31, 2022 | 11.43 Mn |
| Mar 31, 2022 | 11.43 Mn |
| Dec 31, 2021 | 7.66 Mn |
| Dec 31, 2021 | 7.66 Mn |
| Sep 30, 2021 | 10.01 Mn |
| Sep 30, 2021 | 10.01 Mn |
| Jun 30, 2021 | 13.53 Mn |
| Jun 30, 2021 | 13.53 Mn |
| Mar 31, 2021 | 12.20 Mn |
| Mar 31, 2021 | 12.20 Mn |
| Dec 31, 2020 | 5.67 Mn |
| Dec 31, 2020 | 5.67 Mn |
| Sep 30, 2020 | 5.85 Mn |
| Sep 30, 2020 | 5.85 Mn |
| Jun 30, 2020 | 5.42 Mn |
| Jun 30, 2020 | 5.42 Mn |
| Mar 31, 2020 | 6.22 Mn |
| Mar 31, 2020 | 6.22 Mn |
| Dec 31, 2019 | 6.34 Mn |
| Dec 31, 2019 | 6.34 Mn |
| Sep 30, 2019 | 6.56 Mn |
| Sep 30, 2019 | 6.56 Mn |
| Jun 30, 2019 | 6.49 Mn |
| Jun 30, 2019 | 6.49 Mn |
| Mar 31, 2019 | 7.86 Mn |
| Mar 31, 2019 | 7.86 Mn |
| Dec 31, 2018 | 6.35 Mn |
| Dec 31, 2018 | 6.35 Mn |
| Sep 30, 2018 | 6.70 Mn |
| Sep 30, 2018 | 6.70 Mn |
| Jun 30, 2018 | 7.02 Mn |
| Jun 30, 2018 | 7.02 Mn |
| Mar 31, 2018 | 6.53 Mn |
| Mar 31, 2018 | 6.53 Mn |
| Sep 30, 2017 | 4.47 Mn |
| Sep 30, 2017 | 4.47 Mn |
| Jun 30, 2017 | 5.02 Mn |
| Jun 30, 2017 | 5.02 Mn |
| Mar 31, 2017 | 5.80 Mn |
| Mar 31, 2017 | 5.80 Mn |
| Dec 31, 2016 | 3.78 Mn |
| Dec 31, 2016 | 3.78 Mn |
| Sep 30, 2016 | 3.69 Mn |
| Sep 30, 2016 | 3.69 Mn |
| Jun 30, 2016 | 5.20 Mn |
| Jun 30, 2016 | 5.20 Mn |
| Mar 31, 2016 | 4.21 Mn |
| Mar 31, 2016 | 4.21 Mn |
| Dec 31, 2015 | 1.95 Mn |
| Dec 31, 2015 | 1.95 Mn |
| Sep 30, 2015 | 1.06 Mn |
| Sep 30, 2015 | 1.06 Mn |
| Jun 30, 2015 | 440,000.00 |
| Jun 30, 2015 | 440,000.00 |
| Mar 31, 2015 | 65,000.00 |
| Mar 31, 2015 | 65,000.00 |